Park National Corp OH purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,731 shares of the company’s stock, valued at approximately $2,021,000.
Several other large investors have also recently bought and sold shares of HCA. Morgan Stanley boosted its holdings in HCA Healthcare by 8.7% during the third quarter. Morgan Stanley now owns 365,549 shares of the company’s stock worth $45,577,000 after buying an additional 29,148 shares in the last quarter. ExodusPoint Capital Management LP boosted its stake in shares of HCA Healthcare by 27.6% during the 3rd quarter. ExodusPoint Capital Management LP now owns 17,586 shares of the company’s stock worth $2,193,000 after acquiring an additional 3,805 shares in the last quarter. Eudaimonia Partners LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at about $38,000. Lombard Odier Asset Management Europe Ltd acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $290,000. Finally, Point72 Hong Kong Ltd raised its holdings in HCA Healthcare by 280.5% in the 3rd quarter. Point72 Hong Kong Ltd now owns 4,908 shares of the company’s stock valued at $612,000 after buying an additional 3,618 shares during the period. 68.69% of the stock is owned by hedge funds and other institutional investors.
A number of equities analysts recently weighed in on the stock. TheStreet raised shares of HCA Healthcare from a “c+” rating to a “b” rating in a research report on Tuesday, February 2nd. The Goldman Sachs Group initiated coverage on HCA Healthcare in a research note on Tuesday, December 15th. They issued a “buy” rating and a $191.00 price objective for the company. JPMorgan Chase & Co. upgraded HCA Healthcare from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $143.00 to $194.00 in a report on Monday, December 14th. Citigroup lifted their target price on HCA Healthcare from $185.00 to $191.00 in a report on Wednesday, February 3rd. Finally, Mizuho lifted their target price on HCA Healthcare from $180.00 to $195.00 and gave the company a “buy” rating in a report on Friday, February 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $169.47.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, February 2nd. The company reported $4.13 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.63 by $0.50. The business had revenue of $14.29 billion for the quarter, compared to analyst estimates of $13.99 billion. HCA Healthcare had a return on equity of 2,032.72% and a net margin of 6.70%. The company’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.09 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 7.01 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 31st. Investors of record on Wednesday, March 17th were paid a $0.48 dividend. The ex-dividend date was Tuesday, March 16th. This represents a $1.92 dividend on an annualized basis and a yield of 1.03%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.43. HCA Healthcare’s dividend payout ratio is presently 18.29%.
In other HCA Healthcare news, Director Wayne Joseph Riley sold 1,650 shares of the stock in a transaction on Monday, March 8th. The stock was sold at an average price of $190.00, for a total transaction of $313,500.00. Following the transaction, the director now owns 10,819 shares of the company’s stock, valued at approximately $2,055,610. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jon M. Foster sold 5,432 shares of the stock in a transaction on Wednesday, March 10th. The stock was sold at an average price of $186.18, for a total value of $1,011,329.76. Following the transaction, the insider now directly owns 21,838 shares in the company, valued at approximately $4,065,798.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 109,810 shares of company stock worth $19,453,297. 1.80% of the stock is owned by corporate insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Article: What is a Secondary Public Offering?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.